Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26900868

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial

Author
CORNELIS SMITS, Pieter1 ; HOFMA, Sjoerd2 ; TRILLO NOUCHE, Ramiro11 ; DEN HEIJER, Peter12 ; DER ENT, Martin Van1 ; TOGNI, Mario3 ; VAZQUEZ, Nicolás4 ; VALDES, Mariano5 ; VOUDRIS, Vassilis6 ; SLAGBOOM, Ton7 ; GOY, Jean-Jaques3 ; VUILLOMENET, Andre8 ; SERRA, Antoni10 9
[1] Department of Cardiology, Maasstad Ziekenhuis, Rotterdam, Netherlands
[2] Department of Cardiology, Medisch Centrum Leeuwarden, Leeuwarden, Netherlands
[3] Department of Cardiology, Hôpital Cantonal de Fribourg, Fribourg, Switzerland
[4] Department of Cardiology, Hospitalario Juan Canalejo, Coruña, Spain
[5] Department of Cardiology, Hospital Virgen Arrixaca, Murcia, Spain
[6] Department of Cardiology, Onassis Cardiac Surgery Centre, Athens, Greece
[7] Department of Cardiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands
[8] Department of Cardiology, Kantonsspital Aarau, Aarau, Switzerland
[9] Department of Cardiology, Hospital del Mar, Barcelona, Spain
[10] Department of Cardiology, Hospital Sant Pau, Barcelona, Spain
[11] Department of Cardiology, Hospital de Santiago de Compostela, Santiagio de Compostela, Spain
[12] Department of Cardiology, Amphia Ziekenhuis, Breda, Netherlands
Source

Lancet (British edition). 2013, Vol 381, Num 9867, pp 651-660, 10 p ; ref : 39 ref

CODEN
LANCAO
ISSN
0140-6736
Scientific domain
General medicine general surgery
Publisher
Elsevier, Kidlington
Publication country
United Kingdom
Document type
Article
Language
English
Keyword (fr)
Antibactérien Biomatériau Essai clinique Etude comparative Evérolimus Immunodépresseur Médecine Polymère vecteur Stent à élution médicamenteuse Traitement instrumental Biolimus Essai de non-infériorité Essai randomisé contrôlé Inhibiteur mTOR Inhibiteur synthèse protéique Lactone Macrolide
Keyword (en)
Antibacterial agent Biomaterial Clinical trial Comparative study Everolimus Immunosuppressive agent Medicine Control release polymer Drug eluting stent Instrumentation therapy Biolimus Non-inferiority trial Randomized controlled trial Protein synthesis inhibitor Lactone Macrolide
Keyword (es)
Antibacteriano Biomaterial Ensayo clínico Estudio comparativo Everolimus Inmunodepresor Medicina Polímero vector Stent con liberación de fármaco Tratamiento instrumental Biolimus Ensayo de no inferioridad Ensayo aleatorio controlado Inhibidor síntesis proteica Lactona Macrólido
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B01 General aspects

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents / 002B02S02 Antibacterial agents

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B26 Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)

Discipline
Generalities in medical sciences Pharmacological treatments Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, speech therapy, crenotherapy. Dietary management and various treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
26900868

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web